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INTRODUCTION:  Primary  squamous  cell  carcinoma  (SCC)  of  the  tympanic  membrane  is  exceptionally  rare.
We  describe  the history,  investigation  and  management  of this  disease.
PRESENTATION OF  CASE:  A  68-year-old  woman  presented  with  a three  month  history  of  intermittent
otorrhoea  and  external  ear  canal  (EAC)  pruritus.  Otoscopy  revealed  a polypoidal  granular  nodule,  conﬁned
to  the  posterior  aspect  of  the tympanic  membrane.  Examination  under  anaesthesia  (EUA)  conﬁrmed  that
the  lesion  was  conﬁned  to  the  tympanic  membrane,  with  a  surrounding  rim  of normal  drum.  Biopsiesembrane
ateral temporal bone resection
eck dissection
were  consistent  with  well  differentiated  SCC.
DISCUSSION: Following  discussion  at multi-disciplinary  team  meeting  for treatment  planning,  the  patient
underwent  lateral  temporal  bone  resection  with  ipsilateral  superﬁcial  parotidectomy  and  selective  neck
dissection.  Post-operative  histology  conﬁrmed  an  SCC  conﬁned  to the  tympanic  membrane.
CONCLUSION: SCC  of the tympanic  membrane  is  an extremely  rare  condition.  As  with  early  temporal  bone
SCC,  surgical  resection  with  adjacent  structure  clearance  remains  the primary  treatment  modality.
gical © 2012 Sur
. Introduction
Primary squamous cell carcinoma (SCC) of the tympanic mem-
rane is exceptionally rare. To the best of our knowledge, there are
nly three previously reported cases in the English literature.1–3
We  describe a patient diagnosed with primary SCC of the
ympanic membrane and review previously reported cases. We
lso discuss the presentation, history, investigation, diagnosis, and
anagement of this condition.
.  Presentation of case
A 68-year-old woman presented with a three month history
f intermittent otorrhoea and external auditory canal (EAC) pru-
itus. She had no prior history of ear disease. Otoscopy revealed a
olypoidal granular nodule, conﬁned to the posterior aspect of the
ympanic membrane. This was initially assumed to be secondary
o otitis externa and was  treated with oto-topical preparations, but
ith minimal response. An examination under general anaesthesia
as then performed. At this initial clinical assessment, the lesion
as wholly conﬁned to the tympanic membrane, with a surround
f normal drum separating it from the EAC. Biopsies of the granular
issue were taken. Histology revealed a well differentiated SCC [see
ig. 1].
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The patient was  referred to the Head and Neck Oncology service
for further investigation and management. At repeated exami-
nation, granular tissue was noted once again on the tympanic
membrane, but by this time appeared to be extending onto the
posterior EAC, suggesting a diagnosis of SCC of the ear canal. CT
and MRI  of the temporal bone and neck did not suggest any local
invasion or regional lymphatic disease.
Both pathological analysis of the initial biopsy and radiolog-
ical imaging were discussed at our regional multi disciplinary
team meeting for staging and formulation of a management plan.
The patient underwent lateral temporal bone resection with ipsi-
lateral superﬁcial parotidectomy and selective neck dissection.
Post-operative histology conﬁrmed isolated SCC of the tympanic
membrane. Examination of the granular area; adjacent to the pos-
terior EAC wall; revealed moderate dysplasia but no evidence of
malignancy. Parotid and neck specimens were clear of disease.
3.  Discussion
Isolated SCC of the TM is exceptionally rare. This is the fourth
reported case since the initial description by Gisselsson et al. in
1951.1 In each case, initial symptoms were consistent with chronic
otitis externa and otoscopic examination revealed granular lesions
on the tympanic membrane.1–3
In the three previous cases, initial biopsy was suspicious for but
not diagnostic of malignancy. Deﬁnitive diagnosis was only made
Open access under CC BY-NC-ND license.post-resection.1–3 In contrast, the initial biopsy of our patient’s
tympanic membrane lesion yielded a histological diagnosis of
SCC. Although its apparent extension onto the posterior wall of
the EAC suggested a diagnosis of EAC SCC, deﬁnitive pathology
 BY-NC-ND license.
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Mack  of maturation and cytologic atypia. Irregular basal budding of atypical squamous
pithelium  is present, consistent with invasive squamous cell carcinoma (see red
rrows).
ost-resection conﬁrmed that the invasive component was  entirely
onﬁned to the tympanic membrane.
CT temporal bone is currently the imaging modality of choice
or assessment of malignant lesions of the ear and temporal bones.
or pre-operative work up, it is the best modality to assess for bony
nvasion into the temporal bone and ossicular chain. In our patient,
e included an MRI  scan to assess for any soft tissue invasion of
he EAC or regional lymphatic disease.
As SCC of the tympanic membrane is so rare, there is no consen-
us regarding aetiology, staging, investigation, or management. The
our reported cases including our patient do not suggest any con-
istent demographic or aetiological features; they have occurred
qually in males and females, and over a broad age range (42–70
ears).1–3 Due to its rarity, identifying speciﬁc aetiologic factors
or tympanic membrane SCC has been difﬁcult. It is reasonable to
ostulate that SCC of the tympanic membrane would share sim-
lar risk factors with SCC of EAC. These include diabetes, chronic
titis media, cholesteatoma, chronic otitis externa, tobacco con-
umption, HPV, and exposure to radiation. However, only one of
he four reported patients was diabetic, and none of the patients
resented with any of the other risk factors.
In the absence of a speciﬁc staging system for SCC of tym-
anic membrane, we adopted the Modiﬁed Pittsburg staging
ystem, which is based on the TNM classiﬁcation of temporal bone
arcinoma [Table 1].4 This system includes neoplasms arising from
able 1
odiﬁed Pittsburg staging system of temporal bone carcinoma.4
Status Description
T status
T1 Tumour limited to the EAC, without bone erosion or
soft  tissue extension.
T2  Tumour with limited EAC bone erosion or <0.5 cm soft
tissue extension.
T3 Tumour with full thickness EAC bone erosion, <0.5 cm
soft tissue involvement or tumour involving the
middle ear, mastoid, or both.
T4  Tumour eroding the cochlea, petrous apex, medial wall
of  the middle ear, carotid canal, jugular foramen or
dura,  or >0.5 cm soft tissue involvement or facial nerve
paresis.
N status Identical to nodal status of the other head and neck
cancer  TNM staging system
M  status M1 denotes distant metastasis and considered as stage
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EAC and middle ear, and classiﬁes them according to degree of
invasion.
All reported cases including our own have been managed sur-
gically. The earlier cases were managed with local resection of the
tympanic membrane lesion alone; in the latter two  cases, including
our own, more aggressive surgery was undertaken.1,2 The cartilagi-
nous portion of EAC serves as a poor barrier to spread of malignancy.
Tumour can invade the parotid gland anteriorly, the concha and
post-auricular sulcus posteriorly, and spread into the temporal
bone via the Fissures of Santorini. First echelon lymphatic drainage
of EAC is to the parotid and peri-parotid lymph nodes and often
extends to upper jugular, deep cervical, and mastoid lymph nodes.
We think it is likely that SCC of the tympanic membrane could
potentially spread in a similar manner. Thus, even in the absence of
local invasion or regional lymphatic disease on imaging, we believe
that lateral temporal bone resection with parotidectomy and selec-
tive neck dissection for both staging and loco-regional control is the
appropriate surgical management.
Radiotherapy  as a primary treatment modality is of limited
value for management of temporal bone carcinoma. Adjuvant radi-
ation therapy is indicated in cervical node positive patients. In
general, radiotherapy may  provide limited beneﬁt and so it is gen-
erally believed that combined management modalities consisting
of primary surgical resection followed by radiotherapy improves
survival. Due to the very localized nature of her disease, we did not
feel that the risk of additional morbidity secondary to radiotherapy
was justiﬁed in our patient. In patients deemed unﬁt for surgery,
or with unresectable disease (T3 and T4), palliative chemoradiation
therapy may  be offered.5
Early temporal bone tumours (T1 and T2) carry a good prog-
nosis. Moody et al. and Moffat et al. reported 80–100% ﬁve year
survival rates in patients who had primary surgical resection, with
or without adjuvant radiotherapy. T3 and T4 lesions carry poor
prognosis regardless of treatment, with advanced tumours carry-
ing two year survival rates of less than 40%.4,6 As with other head
and neck cancers, the presence of neck metastasis is associated
with a poorer prognosis. Although prophylactic neck dissection is
a common practice, there is no objective evidence that it improves
survival.
4. Conclusion
SCC of the tympanic membrane is an extremely rare condition.
As with early temporal bone SCC, surgical resection with adjacent
structure clearance remains the primary treatment modality.
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